183 related articles for article (PubMed ID: 29782974)
1. Molecular therapy using siRNA: Recent trends and advances of multi target inhibition of cancer growth.
Jain S; Pathak K; Vaidya A
Int J Biol Macromol; 2018 Sep; 116():880-892. PubMed ID: 29782974
[TBL] [Abstract][Full Text] [Related]
2. Promising approaches of small interfering RNAs (siRNAs) mediated cancer gene therapy.
Senapati D; Patra BC; Kar A; Chini DS; Ghosh S; Patra S; Bhattacharya M
Gene; 2019 Nov; 719():144071. PubMed ID: 31454539
[TBL] [Abstract][Full Text] [Related]
3. Development of RNA interference-based therapeutics and application of multi-target small interfering RNAs.
Li T; Wu M; Zhu YY; Chen J; Chen L
Nucleic Acid Ther; 2014 Aug; 24(4):302-12. PubMed ID: 24796432
[TBL] [Abstract][Full Text] [Related]
4. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
5. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
6. Delivery of small interfering RNAs by nanovesicles for cancer therapy.
Pengnam S; Plianwong S; Yingyongnarongkul BE; Patrojanasophon P; Opanasopit P
Drug Metab Pharmacokinet; 2022 Feb; 42():100425. PubMed ID: 34954489
[TBL] [Abstract][Full Text] [Related]
7. Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential.
Larsson M; Huang WT; Liu DM; Losic D
Cancer Treat Rev; 2017 Apr; 55():128-135. PubMed ID: 28363142
[TBL] [Abstract][Full Text] [Related]
8. RNA interference (RNAi) in hematology.
Scherr M; Steinmann D; Eder M
Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
[TBL] [Abstract][Full Text] [Related]
9. The design, preparation, and evaluation of asymmetric small interfering RNA for specific gene silencing in mammalian cells.
Chang C; Hong SW; Dua P; Kim S; Lee DK
Methods Mol Biol; 2013; 942():135-52. PubMed ID: 23027049
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence.
Fluiter K; Mook OR; Baas F
Methods Mol Biol; 2009; 487():189-203. PubMed ID: 19301648
[TBL] [Abstract][Full Text] [Related]
11. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Based Combination Therapy for Cancer Treatment.
Yhee JY; Son S; Lee H; Kim K
Curr Pharm Des; 2015; 21(22):3158-66. PubMed ID: 26027570
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA for experimental cancer therapy.
Tong AW; Zhang YA; Nemunaitis J
Curr Opin Mol Ther; 2005 Apr; 7(2):114-24. PubMed ID: 15844618
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo inhibition of MRP gene expression and reversal of multidrug resistance by siRNA.
Wu Z; Li X; Zeng Y; Zhuang X; Shen H; Zhu H; Liu H; Xiao H
Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):177-84. PubMed ID: 21073659
[TBL] [Abstract][Full Text] [Related]
15. siRNA and miRNA for the treatment of cancer.
Jankovic R; Radulovic S; Brankovic-Magic M
J BUON; 2009 Sep; 14 Suppl 1():S43-9. PubMed ID: 19785069
[TBL] [Abstract][Full Text] [Related]
16. Advances in siRNA delivery in cancer therapy.
Singh A; Trivedi P; Jain NK
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
[TBL] [Abstract][Full Text] [Related]
17. RNA Interference-Based Cancer Drugs: The Roadblocks, and the "Delivery" of the Promise.
Das M; Musetti S; Huang L
Nucleic Acid Ther; 2019 Apr; 29(2):61-66. PubMed ID: 30562145
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of chemically modified siRNA: Recent trends.
Selvam C; Mutisya D; Prakash S; Ranganna K; Thilagavathi R
Chem Biol Drug Des; 2017 Nov; 90(5):665-678. PubMed ID: 28378934
[TBL] [Abstract][Full Text] [Related]
19. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
[TBL] [Abstract][Full Text] [Related]
20. Short interfering RNA (siRNA): tool or therapeutic?
Cejka D; Losert D; Wacheck V
Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]